Lada helped launch and is a director of Impetus Grants, a program that identifies high-risk high-reward aging research, focusing on counterfactual impact for the field of life extension. Since 2021, they funded more than 150 clinical trials, tools and biomarkers in the field of aging, giving out more than 34 million. She is also a founder of a biotech company developing editing tools for the targets of aging, operating out of stealth in San Francisco, Bay area.